News

ascopubs.org6d
Bispecific Antibodies in Hematologic and Solid Tumors: Current Landscape and Therapeutic Advances
Over the past two decades, monoclonal antibodies (mAbs) have played a pivotal role in cancer treatment; however, their efficacy as anticancer agents is constrained by tumor heterogeneity and the ...
ascopubs.org7d
Redefining Survivorship in Pediatric Oncology: A Fresh Look at a Long-Term Problem
Substantial improvements in childhood cancer survival rates have resulted in a growing population of survivors who are living longer. Unfortunately, these survivors carry a substantial burden of ...
ascopubs.org7d
Incorporating Targeted Therapy Into Neuro-Oncology Practice
Survivorship Care for People Affected by Advanced or Metastatic Cancer: Building on the Recent Multinational Association of Supportive Care in Cancer-ASCO Standards and Practice Recommendations The ...
ascopubs.org3d
Leveraging Electronic Health Records to Examine the Real-World Rates of Cancer Genetics Referrals in a Singapore Health Care Cluster
Outpatient Management of Bispecific Related Toxicities: An Observational Study of Safety Outcomes and Resource Utilization Referral criteria for genetics referrals were based on international ...
ascopubs.org7d
Development of a Machine Learning Algorithm to Predict Abnormalities in Serum Phosphate in a Large Oncology Cohort
Risk Stratification for Sentinel Lymph Node Positivity in Older Women With Early-Stage Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2 Neu–Negative Invasive Breast Cancer This ...
ascopubs.org6d
Gender Disparities in Citations and Altmetric Attention Score in Oncology
Educational Video as an Alternative to Pretest In-Person Genetic Counseling in Candidates for Cancer Genetic Testing: A Randomized Controlled Noninferiority Trial The initial data set was compiled ...
ascopubs.org7d
Endocrine Therapy Omission in Estrogen Receptor–Low (1%-10%) Early-Stage Breast Cancer
Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory KRAS G12C Colorectal Cancer Using the National Cancer ...
ascopubs.org6d
Systemic Therapies for Advanced Hepatocellular Carcinoma: Which Gaps Should We Try to Fill?
Educational Video as an Alternative to Pretest In-Person Genetic Counseling in Candidates for Cancer Genetic Testing: A Randomized Controlled Noninferiority Trial Hepatocellular carcinoma (HCC) is the ...
ascopubs.org13d
Treatment Innovations in Pancreatic Cancer: Putting Patient Priorities First
Emerging Paradigms in Genitourinary Cancers: Integrating Molecular Imaging, Hypoxia-Inducible Factor–Targeted Therapies, and Antibody-Drug Conjugates in Renal Cell and Urothelial Carcinomas Pancreatic ...
ascopubs.org4d
Designing Clinical Trials for Patients With Rare Cancers: Connecting the Zebras
Survivorship Care for People Affected by Advanced or Metastatic Cancer: Building on the Recent Multinational Association of Supportive Care in Cancer-ASCO Standards and Practice Recommendations The ...
ascopubs.org7d
Novel Postneoadjuvant Prognostic Breast Cancer Staging System
Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory KRAS G12C Colorectal Cancer Prognostic staging after ...
ascopubs.org7d
Drug Shortages Demand Action: Policy Changes to Protect Patient Care
Both the magnitude and persistence of drug shortages highlight the need to elucidate the underlying factors that disrupt the production and distribution of essential pharmaceuticals. At the federal ...